Aprecap 125/80mg
| SKU | 1490 |
|---|---|
| Generic For | Aprepitant |
| Strength | 125mg/80mg Kit |
| Manufacturer | Glenmark |
| Active Ingredient | Aprepitant |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 3 Capsule/s | US$ 6.60 | US$ 19.80 | |||
|
|||||
| 6 Capsule/s | US$ 3.30 | US$ 19.80 | |||
|
|||||
| 9 Capsule/s | US$ 6.60 | US$ 59.40 | |||
|
|||||
Aprecap 125/80mg (Aprepitant)
Aprepitant is the primary active ingredient present in the drug Aprecap 125/80 mg. It is a medicinal drug that belongs to a category of medication known as substance P antagonists (SPA). It mediates its result by blocking the neurokinin receptor.
What is Aprecap 125/80 mg used for?
Aprecap 125/80 mg employed for the treatment of acute and delayed nausea, and projection related to initial and repeat courses of extremely emetogenic cancer therapy together with high-dose cisplatin, nausea, and screening related to initial and repeat courses of moderately emetogenic cancer therapy.
What medication interact with Aprecap 125 mg/80 mg?
Avoid consuming this drug along with bumetanide, furosemide, hydrochlorothiazide, gentamycin, tobramycin, amphotericin B, ibuprofen, tacrolimus, vancomycin.While using this medication, you ought to not be treated with alternative bisphosphonates, together with alternative brands of Aprecap accustomed forestall or treat bone loss.
Always consult your physician and pharmacist if you are taking any other medicines, which are not prescribed such as herbal tonics, supplements, and medications
When should Aprecap 125 mg/80 mg not be used?
- Aprecap 125/80 mg should not be used if the patient is allergic to the composition of this drug
- This medication should not be prescribed to children below ten years of age
- Please consult your doctor before taking this medicine if you are planning to conceive or you are lactating women
How should Aprecap 125 mg/80 mg be used?
This medication should be utilized consumed as a whole tablet with sufficient amount of water. Swallow this capsule and do not chew or crush the pill. When you buy this drug online from our website Premiumrxdrugs.com, make sure to keep a note of all the instructions and precautions to be followed. If you still have any query do consult your physician and do as instructed.
How long should Aprecap 125 mg/80 mg be used?
Use this medication as per the prescription of your doctor. The initial dose of this medication for adults is once every 3 to 4 weeks. Do not stop taking this medicine without the consent of your doctor even if your symptoms are subsided.
Missed dose of Aprecap 125 mg/80 mg
If you have missed a dose take is as soon as you remember. Please avoid taking any dose if it is already the time to take the next dose.
How should Aprecap 125 mg/80 mg be stored?
Store this medication in a cool, dry placeand out of the reach of your children and pets. The medicines must not be used past the expiry date. Dispose of the wrapper properly. Do not refrigerate the drug.
What are the side effects of the Aprecap 125 mg/80 mg?
Some of the most common side effects related to the consumption of this drug are inflammation, itching, rashes, weight gain, profuse sweating, vertigo, problems in breathing, suffocation, dark urine, increased heart palpitation, cough, cold, nausea, vomiting, puffy face and neck, dizziness, change of vision, dull skin, and paralysis.
What is Aprepitant and what condition does it treat?
Aprepitant is a prescription antiemetic medication used to prevent nausea and vomiting caused by chemotherapy and surgery. Marketed as Aprecap 125/80mg among other brand names, this neurokinin-1 (NK1) receptor antagonist helps cancer patients undergoing highly emetogenic chemotherapy regimens maintain comfort and nutrition. The medicine is particularly effective against delayed nausea that can occur days after treatment. Aprepitant belongs to a specialized class of anti-nausea drugs that work differently from older antiemetics, targeting specific brain receptors responsible for triggering the vomiting reflex during cancer treatment.
How does Aprepitant work in the body?
Aprepitant works by blocking neurokinin-1 (NK1) receptors in the brain's vomiting center, preventing nausea signals before they start. Unlike traditional anti-sickness medicines that work on serotonin pathways, this NK1 antagonist targets substance P, a chemical messenger that triggers vomiting during chemotherapy. Aprecap 125/80mg crosses into the central nervous system where it selectively binds to these receptors for extended periods, providing protection against both acute and delayed chemotherapy-induced nausea. This unique mechanism makes aprepitant especially valuable when combined with other antiemetics for comprehensive nausea prevention throughout multi-day chemotherapy cycles.
How long does Aprecap 125/80mg take to work?
Aprecap 125/80mg begins working within one hour after oral administration, with peak blood levels reached in approximately four hours. The initial 125mg dose taken before chemotherapy provides immediate protection against acute nausea during the first 24 hours. The medication's active ingredient, aprepitant, then maintains therapeutic levels for several days, which is why lower 80mg doses are taken on subsequent days. This extended-release effect makes the antiemetic particularly effective against delayed nausea that typically appears 24 to 120 hours after cancer treatment. Most patients experience significant nausea reduction throughout the entire chemotherapy cycle when following the prescribed dosing schedule.
When and how should I take Aprecap 125/80mg?
Take Aprecap 125mg one hour before your chemotherapy session, followed by 80mg once daily on the next two mornings. Swallow the capsules whole with water, with or without food, though taking with a light meal may improve absorption. The typical three-day regimen involves one 125mg dose on day one, then 80mg on days two and three. Maintain consistent timing each day for optimal nausea control. Store capsules at room temperature away from moisture. Always follow your oncologist's specific instructions, as dosing may vary based on your chemotherapy protocol and individual needs.
Is Aprecap 125/80mg safe for long-term use?
Aprecap 125/80mg is designed for short-term use during each chemotherapy cycle rather than continuous long-term daily administration. The standard three-day regimen per cycle has been extensively studied and proven safe when repeated across multiple chemotherapy courses over months. Clinical trials demonstrate that patients can safely use this NK1 receptor antagonist throughout their entire cancer treatment journey without significant cumulative risks. Between chemotherapy cycles, the antiemetic clears from your system, minimizing long-term exposure concerns. Safety profiles remain consistent across repeated cycles, making aprepitant a reliable choice for managing treatment-related nausea throughout extended cancer care protocols.
Can I take Aprecap 125/80mg with other medicines?
Aprecap 125/80mg can interact with numerous medications because aprepitant affects liver enzymes that process other drugs. It's commonly prescribed alongside other antiemetics like ondansetron and dexamethasone as part of comprehensive nausea prevention protocols. However, this NK1 antagonist may reduce effectiveness of hormonal contraceptives, increase blood thinner effects, and interact with certain antifungals, antibiotics, and heart medications. Always inform your healthcare team about all prescription drugs, over-the-counter medicines, and supplements you're taking. Your oncology pharmacist can review your complete medication list to prevent potentially dangerous drug interactions while ensuring optimal chemotherapy nausea control.
How does Aprecap 125/80mg compare to similar medicines in its class?
Aprecap 125/80mg belongs to the NK1 receptor antagonist class alongside medications like fosaprepitant, rolapitant, and netupitant. While all these antiemetics block the same neurokinin pathway, aprepitant offers a well-established safety profile with over two decades of clinical use. Compared to single-dose alternatives like rolapitant, the three-day aprepitant regimen provides adjustable dosing flexibility. Fosaprepitant is simply an intravenous form of the same active ingredient for patients who cannot swallow capsules. Aprecap's dual-dose formulation (125mg and 80mg) has become a gold standard in chemotherapy-induced nausea prevention, widely prescribed across cancer centers globally.
Is the generic Aprepitant as effective as branded versions?
Generic aprepitant is equally effective as branded versions including Aprecap 125/80mg because regulatory authorities require identical active ingredients, strength, and bioavailability. The NK1 receptor blocking action remains the same regardless of manufacturer, delivering equivalent nausea prevention during chemotherapy. Generic antiemetics must demonstrate therapeutic equivalence through rigorous testing before approval, ensuring patients receive the same clinical benefits at lower costs. Many oncology centers now preferentially prescribe generic aprepitant due to cost savings without compromising treatment outcomes. Whether you choose branded Aprecap or generic alternatives, the chemotherapy nausea protection remains scientifically identical.
Why do patients choose PremiumRxDrugs for Aprecap 125/80mg?
Cancer patients select PremiumRxDrugs for Aprecap 125/80mg because of reliable access to authentic antiemetic medications at competitive pricing during extended treatment periods. The pharmacy's decade-plus reputation provides confidence when ordering essential chemotherapy support medications internationally. Our easy reorder system ensures you never run out of nausea prevention medicine between cycles, while discreet packaging respects your privacy. Worldwide shipping with free delivery options reduces financial burden during expensive cancer treatment. Licensed pharmacy credentials guarantee you're receiving genuine aprepitant rather than counterfeit products. Comprehensive prescription management and responsive customer support make ongoing chemotherapy medication needs simpler during challenging treatment times.
What are the common side effects of Aprepitant?
Common side effects of aprepitant include fatigue, hiccups, constipation, diarrhea, decreased appetite, and headache. Some patients experience dizziness, heartburn, or stomach discomfort while taking this antiemetic. Hair loss may occur, though it's often difficult to distinguish from chemotherapy effects. Temporary increases in liver enzymes sometimes appear in blood tests. Most side effects remain mild and manageable compared to the severe nausea this NK1 antagonist prevents. Serious reactions are uncommon but include allergic responses and significant liver problems. Many patients find these minor effects acceptable given the substantial improvement in quality of life during chemotherapy cycles.
Who should avoid taking Aprepitant?
People with known hypersensitivity to aprepitant or any capsule components should avoid this NK1 receptor antagonist. Those taking pimozide or cisapride cannot use aprepitant due to dangerous drug interactions affecting heart rhythm. Patients with severe liver impairment require careful evaluation before starting this antiemetic. Pregnant women should only use aprepitant when benefits clearly outweigh potential risks, and breastfeeding mothers should discuss alternatives with their oncologist. Individuals using certain medications metabolized by liver enzymes need dosage adjustments or alternative nausea treatments. Always disclose your complete medical history and current medications to ensure aprepitant is appropriate for your chemotherapy nausea management needs.
Login
Sign Up
Login
Sign Up